John Curd

John Curd is the co-founder and CEO of PeptiMatrix, a UK-based company focused on replacing animal-derived products in drug development and research. They currently lead the company, which emerged from the University of Nottingham. Previously, as Entrepreneurial Lead at the University, John explored the commercial viability of a peptide hydrogel platform and secured funding to establish PeptiMatrix. John holds a PhD in Biotechnology, an MSc in Oncology with distinction, and a BSc in Biology.